We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Declines To Challenge Reverse Payment Deal

Law360 (March 20, 2009, 12:00 AM EDT) -- The Federal Trade Commission has disclosed that it will not challenge a so-called reverse payment agreement between generic-drug makers Mylan Inc., Dr. Reddy’s Laboratories Inc. and Cobalt Pharmaceuticals Inc. on one...
To view the full article, register now.